[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334139-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334139-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-two-sides-of-indoleamine-23-dioxygenase-2-ido2","The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2)","","Indoleamine 2,3-dioxygenase 1 (IDO1) and IDO2 arose from gene duplication, but IDO2’s biological function remains unclear despite being discovered in 2007 near the IDO1 locus. Owing to high sequence similarity, IDO2 was initially assumed to degrade tryptophan (Trp) like IDO1; however, it shows extremely low Trp catalytic activity. Conflicting studies propose immune modulation via Trp catabolism to kynurenine. This review evaluates IDO2’s functional role beyond Trp metabolism, highlighting evolutionary persistence, low expression in normal human cells, stronger relevance in cancers, and two prevalent SNPs, with emerging evidence for signaling functions and therapeutic targeting potential.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-two-sides-of-indoleamine-23-dioxygenase-2-ido2/334139/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-two-sides-of-indoleamine-23-dioxygenase-2-ido2/334139.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-13","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why was IDO2 initially thought to function like IDO1?","Question",{"text":63,"@type":64},"IDO2 is located near the IDO1 gene and has high sequence similarity, leading to the expectation that it would degrade tryptophan (Trp) similarly to IDO1.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is the key issue with IDO2’s Trp-degrading activity?",{"text":68,"@type":64},"IDO2 displays extremely low catalytic activity toward Trp, making Trp-to-kynurenine explanations less convincing and motivating study of its roles beyond Trp metabolism.",{"name":70,"@type":61,"acceptedAnswer":71},"How does this review characterize IDO2’s relevance to cancer therapy?",{"text":72,"@type":64},"It summarizes evidence that IDO2 may be more than a Trp-degrading enzyme, potentially acting as a signaling molecule in cancer contexts and suggesting it could represent a target for future therapeutic strategies.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334139,1790696785,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Review  \nThe Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2) Chiara Suvieri , Maria Laura Belladonna  and Claudia Volpi *  \nCitation: Suvieri, C.; Belladonna,  \nM.L.; Volpi, C. The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2) . Cells 2024, 13, 1894 . [https://doi.org/10.3390/cells13221894](https://doi.org/10.3390/cells13221894)  \nAcademic Editor: Maurizio Romano  \nReceived: 20 September 2024  \nRevised: 8 November 2024  \nAccepted: 14 November 2024  \nPublished: 16 November 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \nSection of Pharmacology, Department of Medicine and Surgery, University of Perugia, 06129 Perugia, Italy; [chiara.suvieri@unipg.it](chiara.suvieri@unipg.it) (C.S.); [marialaura.belladonna@unipg.it](marialaura.belladonna@unipg.it) (M.L.B.)  \n* Correspondence: [claudia.volpi@unipg.it](claudia.volpi@unipg.it); Tel.: +39-075-5858246  \nAbstract: Indoleamine 2,3-dioxygenase 1 (IDO1) and IDO2 originated from gene duplication before vertebrate divergence. While IDO1 has a well-defined role in immune regulation, the biological role of IDO2 remains unclear. Discovered in 2007, IDO2 is located near the IDO1 gene. Because of their high sequence similarity, IDO2 was initially thought to be a tryptophan (Trp)-degrading enzyme like IDO1 . Differently from what expected, IDO2 displays extremely low catalytic activity toward Trp. Nevertheless, many studies, often contradictory, have tried to demonstrate that IDO2 modulates immune responses by catabolizing Trp into kynurenine, an unconvincing hypothesis linked to an incomplete understanding of IDO2’s activity. In this study, we review IDO2’s functional role beyond Trp metabolism. IDO2’s evolutionary persistence across species, despite being almost inactive as an enzyme, suggests it has some relevant biological importance. IDO2 expression in human normal cells is poor, but significant in various cancers, with two prevalent SNPs. Overall, the comparison of IDO2 to IDO1 as a Trp-degrading enzyme may have led to misunderstandings about IDO2’s true physiological and pathological roles. New insights suggest that IDO2 might function more as a signaling molecule, particularly in cancer contexts, and further studies could reveal its potential as a target for cancer therapy.  \nKeywords: indoleamine 2,3-dioxygenase 2 (IDO2); cancer; signaling function; tryptophan metabolism; indoleamine 2,3-dioxygenase 1 (IDO1); apo-enzyme  \n1. Introduction  \nGene duplication is a key process for acquiring new genes with new functions. This cell-life phenomenon is very common in all three domains, to the point that duplication is estimated to be as frequent as the rates of single nucleotide polymorphisms [1] . The existence of two copies for the same gene allows one copy to accumulate mutations while the other retains its original function. In many cases, the mutation-containing gene becomes a pseudogene; however, it can also evolve as a new functional gene [2,3] .  \nThe proteins indoleamine 2,3-dioxygenase 1 and 2 (IDO1 and IDO2, respectively), were identified as products arising from a gene duplication that occurred before the divergence of vertebrates [4] . Although IDO1 was discovered first, the indoleamine 2,3-dioxygenase found in lower vertebrates seems to be much more similar to IDO2 than to IDO1 [4]; thus IDO2 is probably the original gene and IDO1 its evolutionary product that has acquired new properties and functions, which were absent or only present as a draft in IDO2 . Despite its ancestral origins, the biological functions of IDO2 are still undefined and under investigation. On the contrary, very soon after its discovery, IDO1 was assigned a pivotal role in the mechanisms co","cbCaimQS28Idjqhf","https://ap.wps.com/l/cbCaimQS28Idjqhf","pdf",647461,14,"English","# Abstract\n# Introduction\n## Gene duplication and functional divergence\n## IDO1 vs IDO2 in immune regulation and cancer therapy\n## Current focus of the review","[{\"question\":\"Why was IDO2 initially thought to function like IDO1?\",\"answer\":\"IDO2 is located near the IDO1 gene and has high sequence similarity, leading to the expectation that it would degrade tryptophan (Trp) similarly to IDO1.\"},{\"question\":\"What is the key issue with IDO2’s Trp-degrading activity?\",\"answer\":\"IDO2 displays extremely low catalytic activity toward Trp, making Trp-to-kynurenine explanations less convincing and motivating study of its roles beyond Trp metabolism.\"},{\"question\":\"How does this review characterize IDO2’s relevance to cancer therapy?\",\"answer\":\"It summarizes evidence that IDO2 may be more than a Trp-degrading enzyme, potentially acting as a signaling molecule in cancer contexts and suggesting it could represent a target for future therapeutic strategies.\"}]","The Two Sides of Indoleamine 2,3-Dioxygenase 2 (IDO2) | PDF",1790005477,35]